Gilead Sciences reported additional data on investigational antiviral remdesivir for treatment of COVID-19
On Jul. 10, 2020, Gilead Sciences announced that a comparative analysis of the Phase 3 SIMPLE-Severe trial and…
UT Southwestern, Texas Health launched collaborative study to better understand COVID prevalence in DFW
On Jul. 10, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced that they will…
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
NIH researchers reframed dog-to-human aging comparisons
On Jul. 9, 2020, a study, published in the journal Cell Systems, laid out a new framework for…
Declines in ED visits for TBIs (including concussions) among children from contact sports
On Jul. 9, 2020, the CDC reported that after a decade of increasing rates, contact sportsï¾–related TBI ED…
WHO announced independent panel for Pandemic Preparedness and Response to evaluate world’s response to COVID-19 pandemic
On Jul. 9, 2020, WHO announced the initiation of the Independent Panel for Pandemic Preparedness and Response (IPPR)…
Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
Philips and BioIntelliSense formed strategic collaboration to enhance remote patient monitoring at home
On Jul. 9, 2020, Royal Philips announced it had formed a strategic collaboration with BioIntelliSense, a continuous health…
Altimmune signed agreement with DynPort Vaccine on US Government funding efforts for COVID-19 vaccine candidate, AdCOVIDï¾™
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
Pfizer pledged $100 million to new industry fund to help fight growing threat of antimicrobial resistance
On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action…
Major League Soccer selected OPKO Health’s BioReference Laboratories to provide COVID-19 testing for players and employees
On Jul. 9, 2020, BioReference Laboratories, an OPKO Health company, announced that it will conduct COVID-19 testing for…
Mylan and Fujifilm Kyowa Kirin Biologics announced FDA approval of Hulioï¾® (adalimumab-fkjp)
On Jul. 9, 2020, Mylan and Fujifilm Kyowa Kirin Biologics announced the FDA had approved Hulioï¾® (adalimumab-fkjp), a…
Outdoor light linked with teensï¾’ sleep and mental health
On Jul. 8, 2020, research showed that adolescents who live in areas that have high levels of artificial…
Kleo Pharmaceuticals announced $5 million grant to advance development of COVID-19 hyperimmune globulin mimic as therapeutic for infected patients
On Jul. 8, 2020, Kleo Pharmaceuticals announced that it had received a $5 million grant from the Bill…
NanoViricides reported safety and tolerability of anti-Coronavirus drug candidates observed in animal model
On Jul. 8, 2020, NanoViricides announced that excellent safety and tolerability of the drug candidates it is developing…
HPV test missed twice as many women who develop cervical cancer as cotesting
On Jul. 8, 2020, a Health Trendsï¾™ study from researchers at Quest Diagnostics and the University of Pittsburgh…
USDA announced an initial purchase of vaccine for National Animal Vaccine and Veterinary Countermeasures Bank
On Jul. 8, 2020, the USDA announced the initial purchase of vaccine for the National Animal Vaccine and…
Long-acting injectable form of HIV prevention outperformed daily pill in NIH study
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
The FDA reported false positive results with BD SARS-CoV-2 reagents for the BD Max System
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
National UK study investigated long-term health impacts of COVID-19
On Jul. 7, 2020, a major UK research study – PHOSP-COVID, will investigate the long-term health impacts of…
The FDA reported false positive results with BD SARS-CoV-2 reagents for the BD Max System
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
Oxford COVID-19 study reported face masks work, call for immediate adoption
On Jul. 7, 2020, Oxfordï¾’s Leverhulme Centre for Demographic Science reported that cloth face coverings, even homemade masks…
GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…
Philips introduced first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies
On Jul. 7, 2020, Royal Philips announced it had introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India….
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
In vitro testing of Innovation Pharmasï¾’ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
LabCorp lanuched first digital COVID-19 service that improves the doctor and patient experience
On Jul. 7, 2020, LabCorpï¾® launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
Merck announced analyses showing additional safety and efficacy data for investigational Islatravir in combination with Doravirine in adults with HIV-1 infection
On Jul. 6, 2020, Merck announced a new analyses from the Phase 2b trial evaluating the safety and…
The FDA issued an emergency use authorization for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19
On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…